Liguzinediol Enhances the Inotropic Effect of Rat Hearts via Inhibition of Protein Phosphatase (PP1 and PP2A) Activities-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Liguzinediol Enhances the Inotropic Effect of Rat Hearts via Inhibition of Protein Phosphatase (PP1 and PP2A) Activities

Published:2017-04 Issue:4 Volume:69 Page:236-244
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Li Sha,Huang Huili,Zhang Mengdan,Wang Wei,Xue Shuyin,Gao Ying,Xie Ming,Chen Kesu,Liu Fuming,Chen Long

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference26 articles.

1. The novel compound liguzinediol exerts positive inotropic effects in isolated rat heart via sarcoplasmic reticulum Ca2+ ATPase-dependent mechanism;Chen;Life Sci.,2012

2. Liguzinediol improved the heart function and inhibited myocardial cell apoptosis in rats with heart failure;Li;Acta Pharmacol Sin.,2014

3. Management of chronic heart failure in the older population;Azad;J Geriatr Cardiol.,2014

4. Prescription of beta-blockers in patients with advanced heart failure and preserved leftventricular ejection fraction. Clinical implications and survival;Dobre;Eur J Heart Fail.,2007

5. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study;Rich;J Am Coll Cardiol.,2001

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liguzinediol potentiates the metabolic remodeling by activating the AMPK/SIRT3 pathway and represses Caspase-3/GSDME-mediated pyroptosis to ameliorate cardiotoxicity;Chinese Medicine;2024-06-14

2. Liguzinediol ameliorates doxorubicin-induced cardiotoxicity and potentiates the metabolic remodeling by activating the AMPK/SIRT3 pathway and represses Caspase-3/GSDME-mediated pyroptosis;2024-02-20

3. Ligustrazine and liguzinediol protect against doxorubicin‐induced cardiomyocytes injury by inhibiting mitochondrial apoptosis and autophagy;Clinical and Experimental Pharmacology and Physiology;2023-08-13

4. The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms;Acta Pharmaceutica Sinica B;2023-05

5. Bay 60-7550, a PDE2 inhibitor, exerts positive inotropic effect of rat heart by increasing PKA-mediated phosphorylation of phospholamban;European Journal of Pharmacology;2021-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3